Literature DB >> 9484393

Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia.

S Ono1, K Takahashi, K Jinnai, F Kanda, Y Fukuoka, H Kurisaki, S Mitake, T Inagaki, T Yamano, K Nagao.   

Abstract

Hypersomnia occurs frequently in patients with myotonic dystrophy (MyD). We performed a quantitative immunohistochemical study of serotonin (5-HT)-containing neurons linked to hypersomnia in the dorsal raphe nucleus (DRN) and the superior central nucleus (SCN) in 8 patients with MyD, 5 of whom showed hypersomnia, and in 12 age-matched controls. The densities of 5-HT neurons in the DRN and the SCN were significantly lower in MyD patients with hypersomnia than in MyD patients without hypersomnia and controls. These data suggest that the loss of 5-HT neurons of the DRN and the SCN is associated with the presence of hypersomnia in MyD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9484393     DOI: 10.1212/wnl.50.2.535

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression.

Authors:  Carla Ramon-Duaso; Thomas Gener; Marta Consegal; Cristina Fernández-Avilés; Juan José Gallego; Laura Castarlenas; Maurice S Swanson; Rafael de la Torre; Rafael Maldonado; M Victoria Puig; Patricia Robledo
Journal:  Cereb Cortex       Date:  2019-07-05       Impact factor: 5.357

2.  Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.

Authors:  Stojan Peric; Gorana Mandic-Stojmenovic; Elka Stefanova; Dusanka Savic-Pavicevic; Jovan Pesovic; Vera Ilic; Valerija Dobricic; Ivana Basta; Dragana Lavrnic; Vidosava Rakocevic-Stojanovic
Journal:  J Neurol       Date:  2014-10-28       Impact factor: 4.849

3.  Evaluation of CNS involvement in myotonic dystrophy type 1 and type 2 by transcranial sonography.

Authors:  Christos Krogias; Barbara Bellenberg; Christian Prehn; Ruth Schneider; Saskia H Meves; Ralf Gold; Carsten Lukas; Christiane Schneider-Gold
Journal:  J Neurol       Date:  2014-11-11       Impact factor: 4.849

4.  Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2.

Authors:  Maria Laura Ester Bianchi; Anna Losurdo; Chiara Di Blasi; Massimo Santoro; Marcella Masciullo; Giulia Conte; Venanzio Valenza; Antonello Damiani; Giacomo Della Marca; Gabriella Silvestri
Journal:  Sleep Breath       Date:  2013-12-06       Impact factor: 2.816

5.  Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour.

Authors:  Oscar Hernández-Hernández; Céline Guiraud-Dogan; Géraldine Sicot; Aline Huguet; Sabrina Luilier; Esther Steidl; Stefanie Saenger; Elodie Marciniak; Hélène Obriot; Caroline Chevarin; Annie Nicole; Lucile Revillod; Konstantinos Charizanis; Kuang-Yung Lee; Yasuhiro Suzuki; Takashi Kimura; Tohru Matsuura; Bulmaro Cisneros; Maurice S Swanson; Fabrice Trovero; Bruno Buisson; Jean-Charles Bizot; Michel Hamon; Sandrine Humez; Guillaume Bassez; Friedrich Metzger; Luc Buée; Arnold Munnich; Nicolas Sergeant; Geneviève Gourdon; Mário Gomes-Pereira
Journal:  Brain       Date:  2013-02-11       Impact factor: 13.501

Review 6.  Myotonic dystrophy: RNA pathogenesis comes into focus.

Authors:  Laura P W Ranum; John W Day
Journal:  Am J Hum Genet       Date:  2004-04-02       Impact factor: 11.025

Review 7.  Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.

Authors:  Andrea Romigi; Valentina Franco; Fabio Placidi; Claudio Liguori; Emanuele Rastelli; Giuseppe Vitrani; Diego Centonze; Roberto Massa
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-31       Impact factor: 5.081

Review 8.  Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.

Authors:  D Annane; D H Moore; P R J Barnes; R G Miller
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 9.  Monoaminergic neuropathology in Alzheimer's disease.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles R Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude M Wischik; Patrick R Hof
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

10.  The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease.

Authors:  Martina Minnerop; Bernd Weber; Jan-Christoph Schoene-Bake; Sandra Roeske; Sandra Mirbach; Christian Anspach; Christiane Schneider-Gold; Regina C Betz; Christoph Helmstaedter; Marc Tittgemeyer; Thomas Klockgether; Cornelia Kornblum
Journal:  Brain       Date:  2011-11-29       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.